----

| DELAWARE                                                                            | 72-0925679                                |
|-------------------------------------------------------------------------------------|-------------------------------------------|
| (State      or other jurisdiction of incorporation      or  organization) | (I.R.S.      employer identification no.) |

----

PART I - FINANCIAL INFORMATION

Item 1.
Consolidated FinancialStatements

Consolidated Balance Sheets

Consolidated Statements of Income

Consolidated Statements of CashFlows

Notes to the Consolidated FinancialStatements

Item 2.   Management's Discussion and Analysis ofFinancial Condition and Results of Operations

Item 3.
Quantitative andQualitative Disclosures About Market Risk

Item 4.
Controls andProcedures

PART II - OTHER INFORMATION

Item 5.
OtherInformation 

Item 6.
Exhibits

|   | SIGNATURES  |
|--------|------------------|

|    |   |                                                                                                    |   |
|---------|--------|---------------------------------------------------------------------------------------------------------|--------|
| Exhibit | 31.1   | Certification of Chief Executive Officer pursuant      to section 302 of the Sarbanes-Oxley Act of 2002 |   |
| Exhibit | 31.2   | Certification of Chief Financial Officer pursuant      to section 302 of the Sarbanes-Oxley Act of 2002 |   |
| Exhibit | 32.1   | Certification of Chief Executive Officer pursuant      to section 906 of the Sarbanes-Oxley Act of 2002 |   |
| Exhibit | 32.2   | Certification of Chief Financial Officer pursuant      to section 906 of the Sarbanes-Oxley Act of 2002 |   |
|    |   |                                                                                                    |   |

----

PART I - FINANCIAL INFORMATION

Item 1.  Consolidated FinancialStatements

ConsolidatedBalance Sheets

| ASSETS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |   | March      31, 2009 |       |   | December      31, 2008 |   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------------|------------|--------|------------------------|--------|
| Current      assets:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |   | (Unaudited)         |       |   | (Audited)              |   |
| Cash      and cash      equivalents                                                                                                                                                       |   | $                   | 2,501,971  |   |                   | $      | 2,320,467 |   |
| Trade      and other accounts receivable, net of allowance for doubtful      accounts of $51,619 and       $45,619                                                                                            |   |                | 3,215,112  |   |                   |   | 2,705,145 |   |
| Inventories,      net                                                                                                                                                                     |   |                | 3,818,900  |   |                   |   | 3,727,492 |   |
| Deferred      income taxes,      net                                                                                                                                                      |   |                | 16,000     |   |                   |   | 21,000 |   |
| Prepaid      tax                                                                                                                                                                          |   |                | 239,500    |   |                   |   | 309,000 |   |
| Deposits,      prepaid expenses and other current      assets                                                                                                                             |   |                | 217,624    |   |                   |   | 392,209 |   |
| Total      current      assets                                                                                                                                                                           |   |                | 10,009,107 |   |                   |   | 9,475,313 |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |   |                |       |   |                   |   |   |   |
| Property      and equipment, net of accumulated depreciation of $9,435,604      and      $9,111,067                                                                                       |   |                | 7,164,363  |   |                   |   | 7,305,278 |   |
| Goodwill                                                                                                                                                                   |   |                | 1,564,966  |   |                   |   | 1,564,966 |   |
| Other      intangible assets,      net                                                                                                                                     |   |                | 131,229    |   |                   |   | 143,010 |   |
| Total      assets                                                                                                                                                                         |   | $                   | 18,869,665 |   |                   | $      | 18,488,567 |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |   |                |       |   |                   |   |   |   |
| LIABILITIES      AND SHAREHOLDERS’ EQUITY                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |   |                |       |   |                   |   |   |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |   |                |       |   |                   |   |   |   |
| Current      liabilities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |   |                |       |   |                   |   |   |   |
| Accounts      payable                                                                                                                                                                     |   | $                   | 1,383,663  |   |                   | $      | 1,106,974 |   |
| Accrued      expenses                                                                                                                                                                     |   |                | 323,940    |   |                   |   | 289,527 |   |
| Short      term loan      payable                                                                                                                                                         |   |                | 614,543    |   |                   |   | 638,091 |   |
| Total      current      liabilities                                                                                                                                                                      |   |                | 2,322,146  |   |                   |   | 2,034,592 |   |
| Long      term liabilities:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |   |                |       |   |                   |   |   |   |
| Long      term deferred tax liability,      net                                                                                                                                           |   |                | 295,000    |   |                   |   | 315,500 |   |
| Total      long term      liabilities                                                                                                                                                                    |   |                | 295,000    |   |                   |   | 315,500 |   |
| Total      liabilities                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |   |                | 2,617,146  |   |                   |   | 2,350,092 |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |   |                |       |   |                   |   |   |   |
| Shareholders’      equity:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |   |                |       |   |                   |   |   |   |
| Preferred      stock, $1 par value; 2,000,000 shares authorized, none    issued                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |   |                | -          |   |                   |   | - |   |
| Common      stock, $0.01 par value; 10,000,000 shares authorized, 3,926,491      shares issued, 2,688,291      outstanding                                                                                    |   |                | 39,265     |   |                   |   | 39,265 |   |
| Additional      paid-in-capital                                                                                                                                                           |   |                | 10,275,838 |   |                   |   | 10,243,568 |   |
| Common      stock held in treasury, 1,238,200 shares at cost                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |   |                | (3,380,554 | )      |                   |   | (3,380,554 | ) |
| Retained      earnings                                                                                                                                                                    |   |                | 9,317,970  |   |                   |   | 9,236,196 |   |
| Total      shareholders’      equity                                                                                                                                                               |   |                | 16,252,519 |   |                   |   | 16,138,475 |   |
| Total      liabilities and shareholders’      equity                                                                                                                                               |   | $                   | 18,869,665 |   |                   | $      | 18,488,567 |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |   |                |       |   |                   |   |   |   |

----

ConsolidatedStatements of Income

|                                                                |   | Three months endedMarch 31, |      |   |
|---------------------------------------------------------------------|--------|-----------------------------|-----------|--------|
|                                                                |   | 2009                        |      |   | 2008 |   |   |
| Revenue                                                             |   | $                           | 4,683,454 |   |   | $ | 5,459,742 |   |
| Cost      of sales                                                  |   |                        | 3,739,132 |   |   |   | 4,348,304 |   |
| Gross profit                                                        |   |                        | 944,322   |   |   |   | 1,111,438 |   |
| Selling      and marketing                                          |   |                        | 150,449   |   |   |   | 190,374 |   |
| General      and administrative                                     |   |                        | 575,505   |   |   |   | 616,864 |   |
| Research      and development                                       |   |                        | 68,758    |   |   |   | 83,622 |   |
| Total expense                                                       |   |                        | 794,712   |   |   |   | 890,860 |   |
| Income from      operations                                         |   |                        | 149,610   |   |   |   | 220,578 |   |
| Other      income (expense), net                                    |   |                        | (13,836   | )      |   |   | 4,794 |   |
| Income      before income taxes                                     |   |                        | 135,774   |   |   |   | 225,372 |   |
| Income      tax provision                                           |   |                        | 54,000    |   |   |   | 76,000 |   |
| Net income                                                          |   | $                           | 81,774    |   |   | $ | 149,372 |   |
| Net      income per share – basic                             |   | $                           | 0.03      |   |   | $ | 0.06 |   |
| Net      income per share – diluted                           |   | $                           | 0.03      |   |   | $ | 0.05 |   |
| Weighted      average common sharesOutstanding –    basic     |   |                        | 2,688,291 |   |   |   | 2,711,680 |   |
| Weighted      average common sharesOutstanding –      diluted |   |                        | 2,688,291 |   |   |   | 2,719,385 |   |

----

Consolidated Statements of Cash Flows

|                                                                                                                               |   | Three Months EndedMarch 31, |      |
|------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------------------|-----------|
|                                                                                                                               |   | 2009                        |      |   | 2008 |   |
| Cash      flows from operating activities:                                                                                         |   |                        |      |   |   |   |
| Net income                                                                                                                         |   | $                           | 81,774    |   |   | $ | 149,372 |   |
|  Adjustments      to reconcile net income to net cash provided by    (used      in) operating activities: |   |                        |      |   |   |   |   |   |
| Depreciation and      amortization                                                                                                 |   |                        | 346,628   |   |   |   | 358,482 |   |
| Share based      compensation                                                                                                      |   |                        | 32,270    |   |   |   | 26,970 |   |
| Provision for doubtful      accounts                                                                                               |   |                        | 6,000     |   |   |   | 17,500 |   |
| Deferred tax    assets                                                                                                             |   |                        | (15,500   | ) |   |   | - |   |
| Changes in operating assets and      liabilities:                                                                                  |   |                        |      |   |   |   |   |   |
| Trade and other accounts      receivable                                                                                           |   |                        | (515,967  | ) |   |   | (1,528,599 | ) |
| Inventories                                                                                                                        |   |                        | (91,408   | ) |   |   | (837,465 | ) |
| Deposits, prepaid expenses and      other assets                                                                                   |   |                        | 244,085   |   |   |   | (99,068 | ) |
| Accounts payable and accrued      expenses                                                                                         |   |                        | 311,102   |   |   |   | 1,853,844 |   |
| Net cash provided by (used in)      operating activities                                                                           |   |                        | 398,984   |   |   |   | (58,964 | ) |
|  Cash      flows from investing activities:                                                                                   |   |                        |      |   |   |   |   |   |
| Capital expenditures, net of      disposals                                                                                        |   |                        | (193,932  | ) |   |   | (157,272 | ) |
| Net cash used in investing      activities                                                                                         |   |                        | (193,932  | ) |   |   | (157,272 | ) |
|  Cash      flows from financing activities:                                                                                   |   |                        |      |   |   |   |   |   |
| Payments on acquisition note      payable                                                                                          |   |                        | (23,548   | ) |   |   | (160,034 | ) |
| Net cash used in financing      activities                                                                                         |   |                        | (23,548   | ) |   |   | (160,034 | ) |
| Net      increase (decrease) in cash and cash equivalents                                                                          |   |                        | 181,504   |   |   |   | (376,270 | ) |
| Cash      and cash equivalents at beginning of period                                                                              |   |                        | 2,320,467 |   |   |   | 1,684,411 |   |
| Cash      and cash equivalents at end of period                                                                                    |   | $                           | 2,501,971 |   |   | $ | 1,308,141 |   |
|                                                                                                                               |   |                        |      |   |   |   |   |   |

----

Notes to theConsolidated Financial Statements

| Inventories      consist of the following as of: |   | March      31,2009 |      |   |   |   |   | December      31, 2008 |   |
|--------------------------------------------------|--------|--------------------|-----------|--------|--------|--------|--------|------------------------|--------|
| Raw materials                                    |   | $                  | 1,142,754 |   |   |   |   |                   |   | $ | 1,099,876 |   |
| Work-in-process                             |   |               | 875,041   |   |   |   |   |                   |   |   | 773,245 |   |
| Finished goods                                   |   |               | 1,801,105 |   |   |   |   |                   |   |   | 1,854,371 |   |
|      Total              |   | $                  | 3,818,900 |   |   |   |   |                   |   | $ | 3,727,492 |   |

|                                  |  Three      Months Ended |
|---------------------------------------|-------------------------------|
|                                  |  March      31, 2008     |
| Dividend      Yield                   | 0%                            |   |
| Expected      Volatility              | 40.65%                        |   |
| Risk      Free Interest Rate          | 3.28%                         |   |
| Expected      Option Terms (in years) | 4.5                           |   |

----

| Exercise      Price                                                                        | Number      of Outstanding Shares | Weighted      Average Remaining Contractual Life (years) | Options      Currently Exercisable                 | Average      Fair Value at Grant Date |
|--------------------------------------------------------------------------------------------|-----------------------------------|----------------------------------------------------------|----------------------------------------------------|---------------------------------------|
|                    $ 4.85 | 25,000                            | 0.33                                                     | 25,000                                             | $  0.66                     |
|           7.15                                                         | 96,000                            | 4.76                                                     | 19,200                                             |          2.74          |
| 9.86                                                                                       | 69,000                            | 2.72                                                     | 66,000                                             |         4.22                |
| 12.42                                                                                      | 10,000                            | 3.35                                                     |        4,000                                  |         5.38                |
| 14.10                                                                                      | 10,000                            | 4.18                                                     |              -- |        6.88                      |
| 23.10                                                                                      | 10,000                            | 3.93                                                     |        4,000                                  | 10.77                                 |

|                                 | Non-Vested Options                                                                                |
|--------------------------------------|---------------------------------------------------------------------------------------------------|
|                                 | Number      of Shares                                                                             | Weighted      Average Fair Value |
| Non-vested      at December 31, 2008 |           111,000                                                             |     $  3.46 |
| Granted                              |                      - |                   - |
| Vested                               |            (21,200)                                                      |        3.50 |
| Forfeited                            |              (1,000)                                           |             2.74 |
| Non-vested      at March 31, 2009    |             88,800                                                  |         $  3.48 |

----

Item 2. 

----

|               |   | Three      Months Ending March 31, |      |
|--------------------|--------|------------------------------------|-----------|
|               |   | 2009                               |      |   | % |   |   | 2008 |   |   | % |   |
| United      States |   | $                                  | 2,615,989 |   |   |   | 56 |   |   | $ | 3,066,751 |   |   |   | 56 |   |
| Canada             |   |                               | 946,678   |   |   |   | 20 |   |   |   | 1,341,015 |   |   |   |  25 |   |
| Europe             |   |                               | 801,546   |   |   |   | 17 |   |   |   | 793,608 |   |   |   | 14       |   |
| Pacific      Rim   |   |                               | 151,430   |   |   |   | 3 |   |   |   | 99,653 |   |   |   | 2 |   |
| Other              |   |                               | 167,811   |   |   |   | 4 |   |   |   | 158,715 |   |   |   | 3 |   |
| Total              |   | $                                  | 4,683,454 |   |   |   | 100 |   |   | $ | 5,459,742 |   |   |   | 100 |   |

----

----

----

Item 3. 

Item 4.

----

Item 5. 

Item 6. 

| (a)   | Exhibits |
|-----------------|----------|

|   |           3.1 | By-laws(b) |
|--------|-----------------------------------|------------|

|   |        10.43* | Employment      agreement between James E. Rouse and the Company dated December 26th,      2006.(d) |
|--------|--------------------|-----------------------------------------------------------------------------------------------------|

|   |        10.44* | Employment      agreement between David A. Garrison and the Company dated January 1st,      2007.(d) |
|--------|--------------------|------------------------------------------------------------------------------------------------------|

|   |   31.1 | Certification      of the CEO pursuant to Rule 13a-14(a) or Rule 15(d)-14(a) on page      X-1. |
|--------|------------------|------------------------------------------------------------------------------------------------|

|   |        31.2 | Certification      of the CFO pursuant to Rule 13a-14(a) or Rule 15(d)-14(a) on page      X-2. |
|--------|------------------|------------------------------------------------------------------------------------------------|

|   |        32.1 | Certification      pursuant to 18 U.S.C. §1350 as adopted pursuant to Section 906 of the      Sarbanes-Oxley Act of 2002 on pageX-3. |
|--------|------------------|-------------------------------------------------------------------------------------------------------------------------------------------|

|   |        32.2 | Certification      pursuant to 18 U.S.C. §1350 as adopted pursuant to Section 906 of the      Sarbanes-Oxley Act of 2002 on pageX-4. |
|--------|------------------|-------------------------------------------------------------------------------------------------------------------------------------------|

|   | __________________________ |
|--------|----------------------------|

|   | *      Indicates a management contract or compensatory plan required to be filed      as an exhibit. |
|--------|------------------------------------------------------------------------------------------------------|

| (a)         | Incorporated      by reference from the Company’s Registration Statement on Form S-18 as      filed with the Commission in April 1988, Registration Statement No.      33-20945-FW. |
|-----------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|          (b)         | Incorporated      by reference from the Company’s Form 10-Q for period ended September 30,      2002 as filed with the Commission in November  2002. |
|------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (c)              | Incorporated      by reference from the Company’s Form 8-K as filed with the Commission on      May 21, 2004. |
|-----------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|

| (d)              | Incorporated      by reference from the Company’s Form 10-KSB for period ended December 31,      2006 as filed with the Commission in March of  2007. |
|-----------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|

SIGNATURES

|              | ARRHYTHMIA      RESEARCH TECHNOLOGY, INC.                                                                                                                                                                                                                                                                                                                                                                                                 |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| May      11, 2009 | By:           /s/  James E.      Rouse                                                          |
|              | James E. Rouse                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|              | President and Chief Executive      Officer                                                                                                                                                                                                                                                                                                                                                                                                     |
|              | (Principal Executive      Officer)                                                                                                                                                                                                                                                                                                                                                                                                        |
|              | By:           /s/  David A.      Garrison                                                       |
|              | David A.  Garrison                                                                                                                                                                                                                                                                                                                                                                                                                             |
|              | Executive Vice President and      Chief Financial Officer                                                                                                                                                                                                                                                                                                                                                                                      |
|              | (Principal Financial and      Accounting Officer)                                                                                                                                                                                                                                                                                                                                                                                              |

----

| Number | Exhibit |   |
|--------|---------|--------|

31.1                 Certificationof the CEO pursuant to Rule 13a-14(a) or Rule 15(d)-14(a)

31.2                 Certificationof the CFO pursuant to Rule 13a-14(a) or Rule 15(d)-14(a)

32.1                 Certificationpursuant to 18 U.S.C. §1350 as adopted pursuant to Section 906

      of the Sarbanes-Oxley Actof2002

32.2                 Certificationpursuant to 18 U.S.C. §1350 as adopted pursuant to Section 906

     of the Sarbanes-Oxley Actof2002